The Mystery of Why Some Drugs Vanish

Picture you’re making a pie. You follow the dish to the letter, buying the advised brand names noted, utilizing a thermometer to guarantee your oven is adjusted, and so on. When you go to pull it out of the oven, you discover it’s not a pie at all– it’s a cobbler. Baffled, you call a good friend who’s made the dish before and gotten fantastic outcomes. She bakes the pie once again and experiences the exact same issue– a mystical cobbler where a pie must be. You both call a good friend who made the pie simply the other day, he brings the pie over to reveal it off, however after talking for a while, you find it’s likewise turned into a cobbler.

Sounds odd? And yet this specific circumstance occurs in drug production with disconcerting frequency. Pharmaceutical producers will follow a recognized procedure for producing a drug, however throughout the formation procedure, a somewhat various variation (or polymorph) appears. It might have the exact same chemical formula, however this brand-new polymorph has a somewhat various shape that provides it considerably various homes.

And the actually creepy thing is that the brand-new polymorph isn’t restricted to any single laboratory, anybody who attempts to make the very first polymorph will discover that it has actually merely disappeared. In some cases, even bringing the old polymorph to a laboratory that’s made the brand-new polymorph is enough to make that item change. It’s as if the particular chemical item were eliminated from the world by some supernatural force.

Possibly the most well-known vanishing polymorph was the antiretroviral ritonavir produced by Abbott Laboratories and authorized in 1996 for the treatment of HIV/AIDS. Type I of the drug was offered in gel pills however then it got superseded by Form II in 1998. This type, which had the very same formula, wasn’t as soluble, which rendered it inadequate. Abbott was required to pull the drug from market up until they might reformulate it as a caplet in 1999. The experience cost the business an approximated $250 million (not to discuss the 10s of countless clients who went without necessary medication).

Vanishing polymorphs trigger a lot of legal headaches for drugmakers too. When a Canadian pharmaceutical business desired to produce Form I of ranitidine (AKA Zantac) after the patent ended, they were taken legal action against by the drugmaker Glaxo. Glaxo held the preliminary patent on Form I, in addition to the patent on Form II, and its legal representatives argued that any efforts to produce the previous would undoubtedly lead to traces of the latter. (Glaxo lost the match.)

Why do these polymorphs disappear in the very first location? According to scientists who study solid-state chemistry, all of it boils down to thermodynamics. The very first variation of a drug may be a less thermodynamically steady variation, however one that forms faster. Crystals grow by means of nucleation (or seeding), where one offers a type of scaffold or design template for the others to form. If Form I nucleates much faster, it may predominate till the more steady Form II appears and takes control of.

Naturally, that does not describe why polymorphs appear to disappear worldwide, and this is where things get speculative. The most engaging description for this specific secret is that there are small seed particles of these drugs simply drifting around in the environment. In theory, it just takes one particle to start condensation, so any laboratory that begins to grow the less steady Form I will discover their culture seeded with the more steady Form II rather.

There’s at least some anecdotal proof for this. Scientists operating in Form II drug laboratories who were moved to laboratories growing Form I found the “curse” of Form II appeared to take a trip with them. Furthermore, some Form I drugs have actually been understood to change to Form II after even remaining in the exact same laboratory with them (like the 3rd pal’s pie).

Is there anything we can do to stop it? Well, vanishing polymorphs are a fairly brand-new phenomenon and an active location of research study. In many cases, scientists have actually had the ability to recreate the disappeared polymorphs in laboratories that have actually been safeguarded from climatic and unexpected contamination. In a paper released in 2024, scientists handled to recreate Form I of the HIV/AIDS drug ritonavir by means of ball-mill grinding (sort of a chemistry rock tumbler). Simply put, there’s some hope on the horizon that these polymorphs have not disappeared for great.

Still, it stays among the spookier stories in chemistry.

Lead image: Prince Zaleski / Shutterstock